SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-11-019353
Filing Date
2011-03-31
Accepted
2011-03-31 21:17:11
Documents
1
Period of Report
2011-03-25

Document Format Files

Seq Description Document Type Size
1 v217161_ex.html 3  
1 v217161_ex.xml 3 3221
  Complete submission text file 0001144204-11-019353.txt   4554
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address 33 HARBOUR SQUARE TORONTO A6 M5J 2G2
Business Address
Brusegard David (Reporting) CIK: 0001516920 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-25169 | Film No.: 11728484